CDK4/6 inhibitors in combination therapies: better in company than alone: a mini review

GL Rampioni Vinciguerra, M Sonego, I Segatto… - Frontiers in …, 2022 - frontiersin.org
The cyclin D-CDK4/6 complexes play a pivotal role in controlling the cell cycle. Deregulation
in cyclin D-CDK4/6 pathway has been described in many types of cancer and it invariably …

The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response

A Favero, I Segatto, T Perin… - Wiley Interdisciplinary …, 2021 - Wiley Online Library
Given their intrinsic pleiotropism, microRNAs (miR) play complex biological roles, in both
normal and pathological conditions. Often the same miR can act as oncogene or …

Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer …

JS Vaidya, M Bulsara, M Baum, F Wenz, S Massarut… - bmj, 2020 - bmj.com
Objective To determine whether risk adapted intraoperative radiotherapy, delivered as a
single dose during lumpectomy, can effectively replace postoperative whole breast external …

A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action

E Campaner, A Rustighi, A Zannini, A Cristiani… - Nature …, 2017 - nature.com
The prolyl isomerase PIN1, a critical modifier of multiple signalling pathways, is
overexpressed in the majority of cancers and its activity strongly contributes to tumour …

Effect of delayed targeted intraoperative radiotherapy vs whole-breast radiotherapy on local recurrence and survival: long-term results from the TARGIT-A randomized …

JS Vaidya, M Bulsara, C Saunders, H Flyger… - JAMA …, 2020 - jamanetwork.com
Importance Conventional adjuvant radiotherapy for breast cancer given daily for several
weeks is onerous and expensive. Some patients may be obliged to choose a mastectomy …

Synthesis and characterization of green zinc oxide nanoparticles with antiproliferative effects through apoptosis induction and microRNA modulation in breast cancer …

AH Aalami, M Mesgari… - Bioinorganic chemistry and …, 2020 - Wiley Online Library
Changes in the expression of microRNAs can affect cancer cells' viability and behavior and
the impact on cancer treatment. In this study, the expression of miR‐155‐5p, miR‐203a‐3p …

[HTML][HTML] MiR-223-3p in cancer development and cancer drug resistance: same coin, different faces

D Barbagallo, D Ponti, B Bassani, A Bruno… - International Journal of …, 2024 - mdpi.com
MicroRNAs (miRNAs) are mighty post-transcriptional regulators in cell physiology and
pathophysiology. In this review, we focus on the role of miR-223-3p (henceforth miR-223) in …

Downregulation of miR-223 expression is an early event during mammary transformation and confers resistance to CDK4/6 inhibitors in luminal breast cancer

F Citron, I Segatto, GLR Vinciguerra, L Musco… - Cancer …, 2020 - aacrjournals.org
Abstract miR-223 is an anti-inflammatory miRNA that in cancer acts either as an
oncosuppressor or oncopromoter, in a context-dependent manner. In breast cancer, we …

The role of miRNA-223 in cancer: Function, diagnosis and therapy

Y Gao, L Lin, T Li, J Yang, Y Wei - Gene, 2017 - Elsevier
MicroRNAs (miRNAs) constitute a large family of small, non-coding RNAs with the capacity
to regulate gene expression post-transcriptionally. miRNAs appear to hold promise of …

Intraoperative radiotherapy for breast cancer

EER Harris, W Small Jr - Frontiers in oncology, 2017 - frontiersin.org
Intraoperative radiotherapy (IORT) for early stage breast cancer is a technique for partial
breast irradiation. There are several technologies in clinical use to perform breast IORT …